Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc.
C.AGN
Alternate Symbol(s):
AGNPF
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Jan 09, 2024 6:41pm
Today’s Trading
Interesting! Seven (7) trades today. After closing at 0.095 yesterday and hours of inactivity today, Desjardins makes an $85 trade so the market price is 0.085. Next we have TD Securities buying 2000
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Jan 08, 2024 1:23pm
Today’s Trading
Only one trade today - knocking 11%%, $200,000 off a company whose research could bring relief from suffering to millions of people. the seller is Desjardins, whose web site states that it is "
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Jan 03, 2024 11:00am
Today’s Tradink
An encouraging start to trading worth share price quickly rising to $0.105. However, we have al learned to expect price depressing mini trades to claw back the gains. Well, it has started with a
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Comment by
nodaytrader
on Jan 02, 2024 3:41pm
RE:RE:Today’s Trading
Vous avez raison de dire que les actions sont dcotes La lettre d'intention de Seyltx signifie qu'un groupe d'investisseurs sophistiqus est prt investir entre 11 et 14 millions
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 27, 2023 4:01pm
New Press Release - Algernon Pharmaceuticals Announces Closing of Private Placement
VANCOUVER, British Columbia, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”) a Canadian clinical stage pharmaceutical development company announces the close of its non-brokered private placement, previously...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 27, 2023 7:00am
New Press Release - Algernon Pharmaceuticals Announces Increase to Private Placement
VANCOUVER, British Columbia, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”) a Canadian clinical stage pharmaceutical development company announces an increase to its non-brokered private placement...
read article.
(4)
•••
renegadesled
X
View Profile
View Bullboard History
Comment by
renegadesled
on Dec 20, 2023 5:27pm
RE:Today’s Trading
Faut attendre....avec la dernire vente de 2 millions de $....a peux prendre j usqu' 3 mois.apres,ils vont avoir du cash pour continuer ....en fait,l action est rabais en ce
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Dec 19, 2023 2:40pm
Today’s Trading
Desjardins is active in trading today and is pre-eminent in the depth chart, suggesting that it is interested in buying but only at progressively lower prices.I find that puzzling! A Google search
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 12, 2023 7:42pm
New Press Release - Algernon Pharmaceuticals Announces Private Placement
VANCOUVER, British Columbia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”) a Canadian clinical stage pharmaceutical development company announces a non-brokered private placement for gross proceeds of $150...
read article.
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Dec 04, 2023 3:41pm
Today’s Trading
The trend is now well established. Integral is nowhere on the CSE Depth Display and the mini trades, $75 to $150, all involvie Desjardins and National Bank. Plus ca change, plus le meme chose
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 30, 2023 7:00am
New Press Release - Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD
VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has received a notice of intention to...
read article.
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Nov 28, 2023 12:15pm
Today’s Trading
Down from 9 cents to 7.5 cents today with a total 12 trades so far. All mini trades - the largest being $300 - and all involving National or Desjardins. Quebec rules the sandbox!
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Nov 27, 2023 1:47pm
Trading Update
Price now down to 8 cents. 10 trades so far today. First 5 involve National Bank followed by 5 involving Desjardins.
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Nov 27, 2023 11:52am
Todo Trading
Great news from Algernon last week and today, suddenly, we have four trades only, all involving National Bank,that drop the price by a whopping 23%! Two things to note on the CSE Depth Chart
...more
(547)
•••
TrevorAbes
X
View Profile
View Bullboard History
Post by
TrevorAbes
on Nov 22, 2023 12:07pm
Microcap penny stock up big on asset sale
https://stockhouse.com/news/the-market-herald-news/2023/11/22/microcap-penny-stock-up-big-on-asset-sale
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed